Upcoming Events
  1. Consumer training workshops

    July 17 @ 12:30 pm - 2:00 pm
  2. Conducting systematic reviews: A short course for thoracic oncology nurses

    August 5 @ 6:30 pm
  3. 6th ALTG Lung Cancer Preceptorship

    October 23 @ 10:00 am - October 24 @ 3:30 pm
  4. ALTG open MAC and SAC meetings

    November 20

Thoracic oncology highlights from ASCO2020 webinar- recording and evaluation survey

Please fill in the evaluation survey if you have not already done so by clicking on the survey icon at the base of your webinar console.

Please access the recording and evaluation survey here

ALTG awarded $12 million in funding

The ALTG is pleased to announce over $12 million in funding has been successfully awarded to ALTG, NHMRC Clinical Trial Centre and the Australian Genomic Cancer Medicine Centre for the ASPiRATION project. In this ground-breaking precision medicine study, led by ALTG President A/Prof Nick Pavlakis and ALTG Scientific Advisory Committee Chair, Prof Ben Solomon, ASPiRATION will explore the benefit of routine comprehensive genomic profiling in 1000 newly-diagnosed metastatic, non-squamous, NSCLC patients in Australia. The enhanced genomic profiling will assist in personalising patient care by matching patients to targeted treatments as early as possible to improve patient outcomes.

Who’s Who

This issue we welcome a new face to the Lung Foundation – Jane Kerr – who will be known to many of our members through her previous roles in both the pharmaceutical industry and clinical work.

Jane Kerr

Please tell us a little about yourself and how you came to be involved with the Lung Foundation

My background is as a respiratory clinical nurse consultant who moved into the pharma industry in the therapeutic area of oncology, mostly specifically in the lung cancer arena. My involvement with the Lung Foundation came about well over 10 years ago through sponsorships from the various companies I worked for and mostly through membership of the LCCG.

What is your role within the Lung Foundation and what are your priorities?

My role with the Lung Foundation is as the General Manger: Thoracic Cancers and Rare Lung Disease. My priority is to have patients, carers and survivors front and centre of all that we do.

What are you most looking forward to in working at the Lung Foundation?

Working with a dedicated group of people in therapeutic areas I’ve always been passionate about.